Andrew S. Kitzmiller - 25 Feb 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
EVP & CFO
Signature
/s/ Andrew S. Kitzmiller
Issuer symbol
N/A
Transactions as of
25 Feb 2022
Net transactions value
+$100,166
Form type
4
Filing time
28 Feb 2022, 13:40:31 UTC
Previous filing
22 Feb 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Purchase $100,166 +4,028 +54% $24.87 11,528 25 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $24.8251 to $24.8698. The Reporting Person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.